The global brain tumor treatment industry size is anticipated to reach a market value of US$ 3,114.2 million in 2023 and US$ 6,228.2 million by 2033, registering a CAGR of 7.2% during the forecast period. Key factors that are anticipated to foster the expansion of the brain tumour diagnosis market globally include the rising prevalence …
Category Archives: Healthcare Trends
Global Conjunctivitis Industry is forecasted to attain US$ 3208.7 Million by 2032, states a recent FMI report
The global conjunctivitis industry size has demonstrated robust growth, showcasing a 5.8% Compound Annual Growth Rate (CAGR) and achieving a substantial value of US$ 1825.8 million by 2022. With a promising outlook, industry experts project an impressive surge, estimating the market to expand significantly and reach approximately US$ 3208.7 million by 2032. Conjunctivitis, commonly known …
Global Cardiac Rhythm Remote Monitoring Devices Industry could surpass US$ 7,985.6 Million by 2033, propelled by enhanced integration with electronic health records | FMI
The global cardiac rhythm remote monitoring devices industry size is slated to exceed a valuation of US$ 4,782.1 million in 2023 and is poised to attain a valuation of US$ 7,985.6 million by 2033. The cardiac rhythm remote monitoring devices industry share is estimated to thrive at a CAGR of 5.3% from 2023 to 2033. …
Global Ligament Augmentation Industry robust growth is anticipated to drive Orthopedics beyond the US$ 80.3 Million by 2033, according to FMI reports
In 2023, the global ligament augmentation industry size is expected to be worth US$ 45.7 million. The market is projected to grow at a CAGR of 5.8% during the forecast period, reaching US$ 80.3 million by 2033. Several factors drive the ligament augmentation industry. One key driver is the increasing prevalence of ligament injuries, particularly …
Global Cryoballoon Ablation System Industry reaching US$ 1.8 Billion by 2033, with a growth rate of 4.9% | FMI
The global cryoballoon ablation system industry size is estimated to register a valuation of US$ 1.1 billion in 2023 and reach US$ 1.8 billion by 2033. The global market is projected with a CAGR of 4.9% during the forecast period. The use of cryoballoon ablation systems to treat heart attacks, dementia, and death is anticipated to spread …
Global Blood Fluid Warming System Industry is anticipated to achieve US$ 2,264.6 Million by 2033 | FMI
In 2023, the global blood fluid warming system industry is projected to be worth US$ 1,083.8 million. There is a general demand for blood fluid warming systems due to the toll that accidents, mishaps, and gunshot wounds have taken on human lives, the over 1,300 hypothermic deaths that have occurred in the past ten years, …
Global Manual Resuscitator Industry on an Upward Trajectory, Forecasted to Hit US$ 845.3 Million by 2030 at 5.7% CAGR | FMI
According to research by ESOMAR-certified company Future Market Insights, the Global Manual Resuscitator Industry is expected to reach a valuation of US$ 845.3 million by 2030. (FMI). in a recent market research. Breathlessness is the first symptom of COPD (chronic obstructive pulmonary disease), one of the most serious diseases. According to the WHO, the number of …
Global Automated Cell Culture Systems Industry Aims for US$ 20.87 Billion by 2030, Backed by FMI’s Projections of 8.4% CAGR
The Global Automated Cell Culture Systems Industry is poised for unprecedented growth, with a compelling Compound Annual Growth Rate (CAGR) of 8.4%. According to the latest projections, the market is set to surge from its 2022 valuation of US$ 10.91 Billion to an impressive US$ 20.87 Billion by 2030. This remarkable expansion is underlined by …
Global Oligonucleotide API Industry Poised for a Remarkable US$ 5.36 Billion Growth, Fueled by a Steady 10.2% CAGR till 2030 | FMI
The Global Oligonucleotide API Market is poised for substantial growth between 2022 and 2030, with a robust CAGR of 10.2%, primarily driven by the increasing demand for innovative drug classes. Consequently, it is projected that by the close of 2030, the global market for oligonucleotide Active Pharmaceutical Ingredients (APIs) will have surged from a valuation of US$ …
Global Injectable Benzodiazepine Industry Set to Achieve US$ 356 Million by 2032 with a Noteworthy 2.7% CAGR | FMI
Sales of the Global Injectable Benzodiazepine Industry are predicted to reach $274 million by the end of 2022. Sales of injectable benzodiazepines are predicted to reach US$ 356 million by 2032’s end. From 2022 to 2032, the injectable benzodiazepines market is anticipated to expand at a 2.7% CAGR. Global Injectable Benzodiazepine Industry sales are set to …